Wednesday, October 29, 2014 12:04:44 AM
“It is not merely our goal, but our obligation to bring Dr. Flynn’s extraordinary work in the field of early cancer detection and potential treatment to the world medical community. Just as we have demonstrated in the past, we intend to identify one or more appropriate Fortune 500 industrial partners in the pharmaceutical and medical device industries to bring product to the market.”
"The SQUID sensor has the ability to detect the small magnetic fields from nanoparticles that have attached to the cancer cells. With this biomagnetic imaging technique, it is possible to identify and image small clusters of cancer cells in a rather novel method, substantially increasing the sensitivity for finding cancer at an earlier stage than is currently available, and without the use of ionizing radiation or large magnetic fields. This biomagnetic sensor method is applicable to breast, ovarian, leukemia, prostate, skin melanoma, and other cancers.”
Recent MHTX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 07:12:38 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 07:44:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:04:24 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM